ARTICLE | Company News
StemCyte, Academia Sinica deal
December 7, 2009 8:00 AM UTC
StemCyte received an exclusive license to the university's IP and certain methods covering the use of stem cell to treat chronic stroke. The university's technology is in Phase II testing. StemCyte sa...